LNA Santé (LNA) Q2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 TU earnings summary
26 Aug, 2026Executive summary
Operating revenue for H1 2025 reached €430.6 million, up 9.1% pro forma from 2024, reflecting strong growth across all business lines and geographies.
High occupancy rates were maintained in both French and Belgian nursing homes, with notable expansion in hospitalisation at home (HAH) and outpatient care.
Real estate activity was dynamic, with revenue nearly five times higher year-over-year, supporting the company's growth trajectory.
Financial highlights
Q2 2025 operating revenue was €220.9 million, up 12.1% reported and 9.8% adjusted year-over-year.
H1 2025 operating revenue grew 11.5% reported and 9.1% adjusted, with organic growth at 7.5% and external growth at 1.6%.
Real estate revenue for H1 2025 was €15.8 million, up 375.8% year-over-year.
Outlook and guidance
2025 operating revenue target revised upward to €860 million, reflecting confidence in continued growth.
Plans to launch two new HAH platforms in Caen and Rouen and pursue targeted acquisitions by late 2025 or early 2026.
Latest events from LNA Santé
- Revenue up 8.4% to €484m, net profit +8.3%, and 2026 growth guidance raised.LNA
H1 2026 - H1 2024 revenue up 8.2% to €386.3m, with robust organic growth and high occupancy rates.LNA
Q2 2024 TU - Revenue up 8.2%, net profit up 5.1%, and leverage improved to 1.69x.LNA
H1 2024 - Nine-month revenue up 9.1% with robust growth in home-based care and high occupancy rates.LNA
Q3 2024 TU - Sales up 10.3% to €793.9m, with 2025 guidance at €845m and 6% organic growth.LNA
H2 2024 - 2024 revenue rose 10.3% to €793.9m, driven by outpatient and homecare growth.LNA
Q4 2024 TU - Q1 2025 delivered 8.9% organic sales growth, led by outpatient care and real estate momentum.LNA
Q1 2025 TU - Strong revenue and EBITDA growth in H1 2025, with ambitious targets confirmed for 2025 and 2031.LNA
H1 2025 - Revenue up 11.4% year-over-year, real estate rebounds, 2025 targets reaffirmed.LNA
Q3 2025 TU